Skip to main content

Table 1 Patient demographics and preoperative parameters

From: Laparoscopic total pelvic exenteration for pelvic malignancies: the technique and short-time outcome of 11 cases

Patient no. Gender Age BMI Preoperative diagnosis Preoperative complications nCRT ASA
1 Male 57 25.3 Bladder transitional cell carcinoma (grade 3) and rectal adenocarcinoma Lower gastrointestinal bleeding No 2
2 Male 62 23.5 Prostate sarcoma (recurrent) Difficult defecation No 2
3 Male 58 19.9 Sigmoid adenocarcinoma (bladder invasion) Rectovesical fistula Colonic obstruction No 2
4 Male 62 23.3 Rectal adenocarcinoma (bladder invasion) Rectovesical fistula No 2
5 Male 75 25.9 Bladder transitional cell carcinoma (grade 2) and rectal adenocarcinoma Acute renal insufficiency Hypertension No 2
6 Female 69 21.7 Sigmoid adenocarcinoma (bladder and uterus invasion) Hypertension No 2
7 Female 55 23.4 Sigmoid adenocarcinoma (bladder invasion) Rectovesical fistula No 2
8 Male 44 24.7 Rectal adenocarcinoma (bladder invasion) Renal calculi No 2
9 Female 65 22.3 Sigmoid adenocarcinoma (bladder invasion) Diabetes mellitus No 2
10 Male 71 25.1 Sigmoid adenocarcinoma (bladder invasion) Benign prostatic hyperplasia colonic obstruction No 2
11 Male 30 20.2 Rectal adenocarcinoma (bladder invasion) Rectal obstruction No 2
Mean   58.9 (median, 62) 23.2     
  1. nCRT neoadjuvant chemoradiotherapy, ASA American Standards Association, BMI body mass index